Mortality News and Research

RSS

Risk stratification tool for COVID-19 patients developed

Researchers have worked on the development of a protocol that could stratify COVID-19 patients based on a scoring system. This new study describing the scoring system for risk stratification is titled, “Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score,” and is published in the latest issue of the British Medical Journal.

9 Sep 2020

Exploring the possibility that mindfulness with paced breathing reduces blood pressure

According to the American Stroke Association and the American Heart Association, more than 100 million Americans have high blood pressure.

9 Sep 2020

Host gene editing main driving force of SARS-CoV-2 mutations

A new study published on the aRxiv preprint server in September 2020 shows that the host immune response, mediated by two RNA editors, causes the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to adapt and change strain characteristics.

9 Sep 2020

COVID-19 pandemic has caused major disruptions to child and maternal health services, show surveys

With the number of under-five deaths at an all-time recorded low of 5.2 million in 2019, disruptions in child and maternal health services due to the COVID-19 pandemic are putting millions of additional lives at stake

9 Sep 2020

Insilico Medicine launches new system for COVID-19 basic and clinical research

Today Insilico Medicine, a global leader in artificial intelligence for drug discovery and development, announced the launch of a new system for COVID-19 basic and clinical research.

9 Sep 2020

Study: Generic cholesterol medications save billions of dollars for Medicare

The switch from brand name to generic cholesterol medications that occurred between 2014 and 2018 has saved Medicare billions of dollars, even as the number of people on cholesterol-lowering drugs has increased, UT Southwestern scientists have calculated.

9 Sep 2020

COVID-19 in pregnancy doubles odds of preterm delivery

The COVID-19 pandemic is continuing to cause huge social, economic, and health-related costs throughout the world, especially in Spain. Clinicians are still coming to terms with the range of health conditions wrought by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A new study published on the preprint server medRxiv* in September 2020 shows that this infection results in fetal and maternal complications.

9 Sep 2020

Vitamin D deficiency can increase risk of COVID-19

Researchers from Israel have found that there could be a link between deficiency of vitamin D and infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their study titled, “The link between vitamin D deficiency and COVID-19 in a large population,” has been released pre-publication at the medRxiv* server.

8 Sep 2020

BU study maps changes in homicide rates across Brazil

A new Boston University School of Public Health study maps changes in homicide rates across Brazil from 2000 through 2014.

8 Sep 2020

Combination of gas embolization and chemotherapy can lead to complete tumor regression

Hepatocellular carcinoma is a particularly stubborn form of cancer with few treatments and a high mortality rate.

8 Sep 2020

Study addresses the role of macrophage activation syndrome in COVID-19

Scientists review macrophage activation syndrome — a feature of the cytokine storm that kills patients with severe cases of COVID-19, as well as possible treatments.

8 Sep 2020

Focal high-intensity focused ultrasound ablation is an effective treatment for prostate cancer

For some prostate cancer patients, radical treatment (surgery or radiation) are treatment standards. However, these procedures may cause side effects including urinary incontinence or impotency.

8 Sep 2020

Limited gut inflammation in COVID-19

A new study by researchers at the Icahn School of Medicine at Mount Sinai and published on the preprint server medRxiv in September 2020 shows that gut infection with this virus produces primarily mucosal immunity but also a limited inflammatory response.

8 Sep 2020

Study finds strong T cell responses in patients recovered from COVID-19

Oxford University researchers have found that natural infection with COVID-19 produces a robust T cell response, including inducing T cell ‘memory’ to potentially fight future infections.

8 Sep 2020

Vitamin D levels in the blood may be a better predictor of future health and disease risks

Free, circulating vitamin D levels in the blood may be a better predictor of future health risks in aging men, according to a study being presented at e-ECE 2020.

7 Sep 2020

D-dimer - A sensitive novel biomarker of COVID-19 mortality

Now, a new study published on the preprint server medRxiv* reports the use of D-dimer in predicting the risk of mortality in COVID-19.

7 Sep 2020

Twitter-propagated COVID-19 misinformation from credible sources has a huge impact

In March, in the early days of the coronavirus pandemic in Europe, a tweet from the French Health Minister, Olivier Verán, advised patients with COVID-19 not to take ibuprofen, an anti-inflammatory drug with analgesic and antipyretic properties.

5 Sep 2020

IU researcher receives NCI grant to study side effects of cancer treatment

A researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center has been awarded a five-year, $5.7 million National Cancer Institute grant to evaluate long-term health outcomes for cancer patients who receive platinum-based chemotherapies.

5 Sep 2020

Ending Preventable Maternal Mortality initiative aims to reduce global maternal mortality by 2030

Ending Preventable Maternal Mortality is a global initiative with the ultimate goal of ending preventable maternal mortality to support achievement of Sustainable Development Goals targets to attain an average global maternal mortality ratio of less than 70 per 100 000 live births by 2030.

5 Sep 2020

Extra priority should be given to worst-off countries in COVID-19 vaccine allocation, says expert

In contrast to WHO´s and other expert´s advice, the worst-off countries should be extra prioritised when it comes to COVID-19 vaccine allocation, according to Professor Ole Frithjof Norheim at the University of Bergen.

4 Sep 2020

Mortality News and Research

Risk stratification tool for COVID-19 patients developed

Exploring the possibility that mindfulness with paced breathing reduces blood pressure

Host gene editing main driving force of SARS-CoV-2 mutations

COVID-19 pandemic has caused major disruptions to child and maternal health services, show surveys

Insilico Medicine launches new system for COVID-19 basic and clinical research

Study: Generic cholesterol medications save billions of dollars for Medicare

COVID-19 in pregnancy doubles odds of preterm delivery

Vitamin D deficiency can increase risk of COVID-19

BU study maps changes in homicide rates across Brazil

Combination of gas embolization and chemotherapy can lead to complete tumor regression

Study addresses the role of macrophage activation syndrome in COVID-19

Focal high-intensity focused ultrasound ablation is an effective treatment for prostate cancer

Limited gut inflammation in COVID-19

Study finds strong T cell responses in patients recovered from COVID-19

Vitamin D levels in the blood may be a better predictor of future health and disease risks

D-dimer - A sensitive novel biomarker of COVID-19 mortality

Twitter-propagated COVID-19 misinformation from credible sources has a huge impact

IU researcher receives NCI grant to study side effects of cancer treatment

Ending Preventable Maternal Mortality initiative aims to reduce global maternal mortality by 2030

Extra priority should be given to worst-off countries in COVID-19 vaccine allocation, says expert

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News